CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Aug 6, 2025, 3:30 PM EDT
Rover Group Market Cap
CBD Life Sciences has a market cap or net worth of $1.30 million as of August 6, 2025. Its market cap has increased by 1,043.54% in one year.
Market Cap
1.30M
Enterprise Value
1.36M
Revenue
178.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 31, 2012, CBD Life Sciences's market cap has decreased from 36.67M to 1.30M, a decrease of -96.46%. That is a compound annual growth rate of -22.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 1.30M | -14.58% |
| Dec 31, 2024 | 1.52M | 3,469.86% |
| Dec 29, 2023 | 42.51K | 4.42% |
| Dec 30, 2022 | 40.71K | -99.50% |
| Dec 31, 2021 | 8.14M | 62.45% |
| Dec 31, 2020 | 5.01M | 909.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |